![](https://www.diabetesnews.com/wp-content/uploads/2012/10/199845-pill_bottle_and_pills_large-150x150.jpg)
Oramed has submitted a protocol to the FDA to initiate a Phase 2a trial of its orally ingestible insulin capsule, ORMD 0801, for type 1 diabetes. The double-blind, randomized, placebo controlled, seven-day study design will be carried out at an inpatient setting on twenty-four type 1 diabetic patients
Read more